Review of the international consensus guidelines for the optimal use of the polymyxins
Polymyxins are often the only agents that remain in vitro active against extensively resistant bacterial pathogens. However, the use of polymyxins is compromised by the number of unresolved issues, including the technical aspects of antimicrobial susceptibility testing, pharmacokinetic and pharmacod...
Main Authors: | Eliseeva E.V., Azyzov I.S., Zubareva N.A. |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
2019-12-01
|
Series: | Клиническая микробиология и антимикробная химиотерапия |
Subjects: | |
Online Access: | https://cmac-journal.ru/publication/2019/4/cmac-2019-t21-n4-p282/cmac-2019-t21-n4-p282.pdf |
Similar Items
-
Polymyxins: To Combine or Not to Combine?
by: Federico Perez, et al.
Published: (2019-04-01) -
Molecular mechanisms of polymyxin resistance and detection of mcr genes
by: Patrik Mlynarcik, et al.
Published: (2019-02-01) -
Corrigendum: Polymyxins and Their Potential Next Generation as Therapeutic Antibiotics
by: Martti Vaara, et al.
Published: (2019-10-01) -
Induction and nosocomial dissemination of carbapenem and polymyxin-resistant Klebsiella pneumoniae
by: Gilberto Gambero Gaspar, et al.
Published: (2015-01-01) -
Non-clonal occurrence of pmrB mutations associated with polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae in Brazil
by: Ana Claudia Souza Rodrigues, et al.
Published: (2019-05-01)